BoneSupport readies $62m IPO

BoneSupport said this week that it’s planning to float an initial public offering that would fetch roughly $62 million at the midpoint, not including an over-allotment option.

The Swedish company, which is developing the Cerament G injectable antibiotic-eluting bone graft substitute, said it plans to offer more than 18.5 million shares at $3.13 to $3.59 apiece (SEK 27 to SEK 31), for total proceeds of $57.9 million to $66.4 million (SEK 500 million to SEK 574 million).

Get the full story at our sister site, Drug Delivery Business News. 

The post BoneSupport readies $62m IPO appeared first on MassDevice.

from MassDevice http://ift.tt/2ssQigu